InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Rey-Giraud Agnes. Director active across 2 companies, notably UpHealth, Inc.. In total, 15 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €281. History available since 10 June 2021. The latest transaction was filed on 12 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rey-Giraud Agnes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
192,185 shares@ US$0.47100.0% of flowClass A Common StockSEC:0001809519-26-000055:0
75,219 shares0Class A Common StockSEC:0001628280-25-040839:0
57,050 shares0Class A Common StockSEC:0001809519-25-000092:0
2,464 shares0Class A Common StockSEC:0001809519-24-000144:0
28,398 shares0Class A Common StockSEC:0001809519-24-000112:0
500 shares@ US$0.61100.0% of flowCommon StockSEC:0000950170-24-070998:0
100,000 shares0Common StockSEC:0001062993-24-001881:0
39,177 shares0Class A Common StockSEC:0000950170-23-028430:0
27,440 shares0Class A Common StockSEC:0000899243-22-022800:0
71,730 shares0Common StockSEC:0001062993-21-013525:0
14,454 shares0Class A Common StockSEC:0000899243-21-036346:0
54,370 shares0Class A Common StockSEC:0000899243-21-035412:0
67,327 shares0Common StockSEC:0001062993-21-007804:0
67,327 shares0Common StockSEC:0001062993-21-007611:0
6,138 shares0Class A Common StockSEC:0000899243-21-023582:0
15 of 15 declarations
About Rey-Giraud Agnes
REY-GIRAUD AGNES is a declarant, and the total number of filings is 15. Among the sampled recent filings, the period runs from 2021-06-14 to 2026-03-13, total purchases are EUR 0 and total sales are EUR 281. The modal transaction nature is Attribution. She is a Director at GoodRx Holdings, Inc. and UpHealth, Inc., and the largest filing shown concerns GoodRx Holdings, Inc. on 2026-03-13 for EUR 78251.14057800215.
